Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 10.80
-0.09 (-0.83%)
May 20, 2026, 11:29 AM CST
SHA:600267 Market Cap
SHA:600267 has a market cap or net worth of 12.61 billion as of May 19, 2026. Its market cap has increased by 19.94% in one year.
Market Cap
12.61B
Enterprise Value
13.23B
Revenue
10.31B
Ranking
n/a
PE Ratio
18.25
Stock Price
10.80
Market Cap Chart
Since August 15, 2006, SHA:600267's market cap has increased from 2.44B to 12.61B, an increase of 418.04%. That is a compound annual growth rate of 8.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 12.61B | 9.66% |
| Dec 31, 2025 | 11.50B | 18.59% |
| Dec 31, 2024 | 9.70B | -12.87% |
| Dec 29, 2023 | 11.13B | -13.94% |
| Dec 30, 2022 | 12.94B | -22.69% |
| Dec 31, 2021 | 16.73B | 4.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing King-Friend Biochemical Pharmaceutical | 13.78B |
| Zhejiang Medicine | 13.41B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.19B |
| Shenzhen Chipscreen Biosciences | 12.89B |
| Hubei Hongyuan Pharmaceutical Technology | 12.75B |
| Shanghai Yizhong Pharmaceutical | 12.66B |
| Guobang Pharma | 12.65B |
| Henan Lingrui Pharmaceutical | 12.42B |